NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 17 May 2011 Clopidogrel* alone is now recommended by NICE with no limits on duration of treatment in people who have had an ischaemic stroke. Modified-release (MR) dipyridamole plus aspirin […]
Category Archives: Cardiovascular disease
NPC Archive Item: Reducing treatment dose errors with low molecular weight heparins
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 06 September 2010 Introduction In July 2010, the National Patient Safety Agency (NPSA) issued its Rapid Response Report: Reducing treatment dose errors with low molecular weight heparins (LMWHs)1, making […]
NPC Archive Item: May Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 26 May 2010 The MHRA and CHM have published the May edition of Drug Safety Update This edition includes […]
NPC Archive Item: What is the place in therapy of simvastatin 80mg in the light of recent MHRA guidance?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25 May 2010 The May edition of Drug Safety Update includes an article advising healthcare professionals that the product information for simvastatin has been updated to highlight the increased […]
NPC Archive Item: Do statins have mortality benefits in heart failure?
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 14 May 2010 This meta-analysis found that while statins reduced hospitalisation for worsening heart failure, they did not significantly reduce all-cause mortality or cardiovascular mortality in people with heart […]
NPC Archive Item: ‘Gold standard’ clinic BP measurements by trained staff are closer to ambulatory BP measurements than clinic measurements by doctors
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 27 April 2010 This Australian observational study found that blood pressure (BP) measured in clinic by specialist staff using immaculate technique was higher than ambulatory BP values by an […]
NPC Archive Item: A key message on intensive blood-pressure control in type 2 diabetes mellitus from ACCORD
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 April 2010 The ACCORD blood-pressure (BP) study conducted in patients with type 2 diabetes at high risk for cardiovascular (CV) disease concluded that intensive BP control to a target […]
NPC Archive Item: Fenofibrate does not reduce CV events in patients with type 2 diabetes when added to simvastatin
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 April 2010 The ACCORD lipid trial in patients with type 2 diabetes concluded that intensifying lipid modification therapy through combination use of fenofibrate and simvastatin (at a daily […]
NPC Archive Item: Concomitant use of clopidogrel and PPIs: European Medicines Agency updates warning
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 April 2010 Following an analysis of new data, the European Medicines Agency has recommended an amendment to the existing warning over the concomitant use of clopidogrel and proton-pump […]
NPC Archive Item: April 2010 Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 09 April 2010 The MHRA and CHM have published the April edition of Drug Safety Update Highlights include: Updated […]